Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally adminis...
Q2 2026
Aug 5, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 25, 2026
Q4 2025
Q3 2025
Nov 4, 2025
